Product Images Dextrose

Freeflex® NDC 65219-234-01 is a 5% dextrose injection with a concentration of 2.5 grams per 50 mL (50 mg per mL). It is intended for intravenous use only and is a single-dose solution. The solution contains dextrose monohydrate and water for injection, and is a moisture barrier when overwrapped. The solution must be used immediately upon removal from overwrap and stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature], protected from freezing. It is a Non-PVC, Non-DEHP, and sterile product, and the container closure is not made with natural rubber latex. The usual dosage must be referred to the package insert, and additivity compatibility must be confirmed with the pharmacist. Finally, dextrose solutions without salts should not be used in blood transfusions due to possible Rouleau formation.*

This is a 5% Dextrose Injection, USP with NDC 65219-234-10 and a size of 50 mL x 60. It should be stored at 20° to 25°C (68° to 77°F) and protected from freezing. The manufacturing company is freeflex by Fresenius Kabi and it is made in Norway. The LOT number is not available.*

Freeflex'® is the brand name of an injectable solution with the National Drug Code (NDC) 65219-236-01. This solution, made by Fresenius Kabi in Norway, is a 5% dextrose injection, USP that contains 5 grams per 100 mL (50 mg per mL) of dextrose monohydrate and water. Each package contains a single dose to be used for intravenous use only, with the usual dosage found in the package insert. The overwrap protects the solution as a moisture barrier, and once unwrapped, the solution should be used immediately. It is essential to store the container in a location where the temperature ranges from 20°C to 25°C and to protect it from freezing. Furthermore, the container closure is sterile and does not contain natural rubber latex or polyvinyl chloride (PVC), or di(2-ethylhexyl) phthalate (DEHP). Dextrose solutions such as this should not be used for blood transfusion due to the possible formation of Rouleau aggregates. Finally, the pharmacist must be consulted for additive compatibility as well as guidelines for introducing additives using aseptic techniques.*

This text provides information about a medication labeled as 5% Dextrose Injection, USP. The medication is distributed by freeflex® and manufactured by Fresenius. It comes in a 100 mL x 50 KABI container and should be stored at a temperature between 20-25°C (68° to 77°F). It is manufactured in Norway and should be protected from freezing. The LOT number is 000000D and the specified quantity is not available.*

This is a product description for a medical solution called freeflex® 5% Dextrose Injection, USP. It is a single dose solution containing 12.5 grams of dextrose per 250 mL (50 mg per mL) intended for intravenous use and available only through prescription. The solution should be used immediately once removed from packaging and should not be frozen. It is made in Germany and distributed in the US by Fresenius Kabi. Additives may be incompatible, and the usual dosage should be followed as indicated in the package insert. The overwrap is a moisture barrier, and the container closure does not contain natural rubber latex. Dextrose solutions without salts should not be used in blood transfusions because they may cause Rouleau formation. In conclusion, it is a common medical product used to replenish blood sugar levels.*

5% Dextrose Injection, USP is a product manufactured by Fresenius Kabi. It comes in the form of a 250 mL freeflex bag and is available in a package of 30. The product should be stored at room temperature, between 20°C to 25°C and should be protected from freezing. The NDC code for this product is 65219-238-25, and the product number is 262325. The package insert also mentions the lot number (0718681/00US) and expiry date (not available in the text).*

The text describes the details of the freeflex® 5% Dextrose Injection, USP, which is a solution used for intravenous purposes with a single dosage only. The solution contains 5 grams of Dextrose monohydrate per 100ml of water for injection. The description includes details regarding the pH, osmolality, and storage conditions. It also warns against using Dextrose solutions without salts in blood transfusions and suggests consulting with the pharmacist before introducing additives. The container closure is specified to be Non-PVC, Non-DEHP, Sterile, and not made with natural rubber latex. The details of the manufacturer, lot number, expiry date, and other relevant information are also provided.*

This is a description of a medical product that is NDC 65219-240-50 and is manufactured by Fresenius Kabi. The product is a 5% Dextrose Injection that comes in a bag that is freeflex©. It has a volume of 500 mL and comes in a package of 20. The product needs to be stored at a controlled room temperature and protected from freezing. There is a code provided on the product as well.*